Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial.

23/11/2023
/ Publications

Published in the Lancet Oncology, this randomized phase 2 study by the Mayo group was set to compare conventional fractionated (50 Gy in 25 fractions of 2 Gy)...

Proton therapy for the management of localized prostate cancer: Long-term clinical outcomes at a comprehensive cancer center.

23/11/2023
/ Publications

Published in the Green Journal, this study by MD Anderson group reported clinical outcomes of 2772 patients with localized prostate cancer treated with proton...

5-Years Analysis of Effectivity and Toxicity of Ultra-Hypofractionated Proton Radiotherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer-A Retrospective Analysis.

23/11/2023
/ Publications

This retrospective study by the group from Proton Therapy Center, Czech, analyzed clinical outcomes of 853 patients with prostate cancer treated with an ultra...

Ensuring continued success at one of the busiest Proton Centers in the world

17/05/2021
/ Webinar
/
PT101

View our Breakfast Briefing Webinar from the virtual NAPT 2021 conference with Jim Metz’ from UPENN presenting on Ensuring continued success at one of the...

Single-Masked Randomized Phase 2 Study Assessing 2 Forms of Hypofractionated Proton Therapy in Patients With Large Choroidal Melanomas.

23/11/2023
/ Publications

This randomized phase 2 trial by multiple groups from France reported that 8 x 6.5 Gy scheme is feasible without deteriorating local control and with similar...

Analysis of the cost-effectiveness of proton beam therapy for unresectable pancreatic cancer in Japan.

23/11/2023
/ Publications

This study from Japan estimated the incremental cost-effectiveness ratio (ICER) of PBT as a replacement for three-dimensional conformal RT (3DCRT). The...

Pencil beam scanning proton therapy for pregnant patients with brain and head and neck cancers.

23/11/2023
/ Publications

Published in the Red Journal, this retrospective study analyzed seven pregnant patients (4 brain tumors and 3 head and neck tumors) treated with XRT and modeled...

Patients' needs in proton therapy: A survey among ten European facilities.

23/11/2023
/ Publications

This is a qualitative analysis of a recent survey took place in 10 PT centers in Europe. Nine centers treat from 100 to 500 patients per year. Pediatric...

Advances and Challenges in Conducting Clinical Trials With Proton Beam Therapy.

23/11/2023
/ Publications

Proton therapy has arisen over the past 2 decades with indications grown beyond pediatric, prostate, spine, and ocular tumors. Calls have been growing for high...

Tumeurs pédiatriques: L'apport de la proton thérapie - Partie 1/4

07/12/2023
/ Webinar

Après une introduction donnée par Claude Dupont, le Professeur émérite Jean-Louis Habrand du Centre de Lutte Contre Le Cancer François Baclesse a évoqué la...